Frangula bark 100mg / Taraxacum 100mg tablets
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
1972–2025
Showing the 50 most relevant studies, sorted by most relevant.
Sigrun Chrubasik, Elon Eisenberg, Edith Balan, et al.
The American Journal of Medicine, 2000
M.E Boucher, A Chaala, H Pakdel, et al.
Biomass and Bioenergy, 2000
Nobuhiro Akashi, Tohru Nakashizuka
Forest Ecology and Management, 1999
Olumayokun A Olajide, S.Olubusayo Awe, J.Modupe Makinde, et al.
Journal of Ethnopharmacology, 2000
T. Tanaka, T. Ito, K. Nakaya, et al.
Phytochemistry, 2000
Michael J. Zwerger, Anna Deisl, Fabian Hammerle, et al.
Journal of chromatography. A, 2024
Liis Luhamaa, Riina Rammo, Debbie Bamford, et al.
Heritage, 2025
Teterovska R, Skotele RE, Maurina B, et al.
2025
- Gastric Acid
- Plants, Medicinal
- Gastrointestinal Diseases
BackgroundGastrointestinal (GI) disorders associated with increased gastric acid secretion, such as gastroesophageal reflux, dyspepsia, bloating, and abdominal pain, significantly impair quality of life and present a substantial healthcare burden. Conventional therapies may have limited efficacy or undesirable side effects, underscoring the need for safe complementary approaches. This study systematically identifies and reviews the medicinal plants used in food supplements (FSs) marketed in Latvia for digestive health, focusing on the conditions linked to excess gastric acid.MethodsA structured literature search was conducted to identify European plant species with proven protective effects on the digestive system or the ability to influence gastric acid levels. A market analysis was performed using the Latvian Food and Veterinary Service FS Register.ResultsA total of 218 FS-containing medicinal plants were identified, of which 15 species were included in at least ten products. The most frequently used plants were peppermint (Mentha piperita), artichoke (Cynara cardunculus), fennel (Foeniculum vulgare), Milk thistle (Silybum marianum), dandelion (Taraxacum officinale), chamomile (Matricaria chamomilla), psyllium (Plantago ovata), licorice (Glycyrrhiza glabra), caraway (Carum carvi), lemon balm (Melissa officinalis), and chicory (Cichorium intybus). Label claims most often referred to supporting digestion, relieving bloating, and maintaining normal GI function. However, the majority of claims lacked robust clinical substantiation, and were based primarily on traditional use. Discrepancies between product information and available scientific evidence highlight regulatory and consumer protection challenges.ConclusionsThis work contributes to the critical evaluation of plant-based FSs for digestive health, emphasizing the need for standardized preparations, harmonized health claim assessment, and further clinical research to establish efficacy and safety.
Abstract licence: CC BY
Liis Luhamaa, Riina Rammo, Debbie Bamford
Studia Vernacula, 2024
Boyko O, Brygadyrenko V
2025
Synthetic anthelmintic drugs not only contribute to the development of pathogen resistance and environmental pollution but also to the development of pathogen resistance. Therefore, identifying the anthelmintic properties of widely used medicinal plants could be of great practical interest to veterinary and human medicine. In our experiment, we evaluated the in vitro survivability of the noninvasive and invasive (L1-2 and L3, respectively) larvae of Strongyloides papillosus and Haemonchus contortus subject to aqueous solutions of ethanolic tinctures of traditional medicinal plants (46 species). Most of the plant species we studied belonged to the families Asteraceae (Achillea millefolium, Arctium lappa, Artemisia absinthium, Bidens tripartita, Calendula officinalis, Cynara cardunculus var. scolymus, Echinacea purpurea, Helichrysum arenarium, Inula helenium, Matricaria chamomilla, Silybum marianum, Tanacetum vulgare, Taraxacum officinale, Tragopogon porrifolius), Rosaceae (Agrimonia eupatoria, Fragaria vesca, Sanguisorba officinalis), and Lamiaceae (Leonurus cardiaca, Mentha × piperita, Origanum vulgare, Salvia officinalis, Thymus vulgaris). Other plant families were represented by 1-3 species: Fabaceae (Glycyrrhiza glabra, Hedysarum alpinum, Trifolium pratense), Salicaceae (Populus nigra, P. tremula, Salix alba), Fagaceae (Quercus robur), Betulaceae (Betula pendula), Juglandaceae (Juglans regia), Rhamnaceae (Frangula alnus), Acoraceae (Acorus calamus), Apiaceae (Foeniculum vulgare), Caprifoliaceae (Valeriana officinalis), Cucurbitaceae (Cucurbita pepo), Equisetaceae (Equisetum arvense), Ericaceae (Vaccinium vitis-idaea), Gentianaceae (Centaurium erythraea), Hypericaceae (Hypericum perforatum), Malvaceae (Althaea officinalis), Plantaginaceae (Linaria vulgaris, Plantago major), Poaceae (Zea mays), Polygonaceae (Polygonum aviculare), and Ranunculaceae (Nigella sativa). We determined Artemisia absinthium, Inula helenium, Matricaria chamomilla, Salvia officinalis, and Populus nigra, whose aqueous solutions of alcohol tinctures demonstrated nematocidal properties. The other plants we studied did not affect the viability of parasitic nematode larvae.
Abstract licence: CC BY
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.